Treatments that contain ledipasvir and sofosbuvir for genotype 1 has success rates of around 93 to 99% but is very expensive.
Trenutna oblika zdravljenje je kombinacija peginterferona alfa in protivirusnega zdravila ribavirina; zdravljenje traja 24 ali 48 tednov, odvisno od virusnega genotipa.